Infanrix Ipv Hib

Diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccine, the active ingredient in Infanrix IPV Hib, is a vaccine presented as an injectable solution for intramuscular use. It induces immunity against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b disease in infants and young children.

GNH USA supplies Infanrix IPV Hib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infanrix IPV Hib is a multivalent vaccine that targets several bacterial and viral pathogens commonly encountered in early childhood. - Diphtheria: provides protective immunity against diphtheria toxin in infants and toddlers. - Tetanus: induces antibodies that prevent tetanus toxin‑mediated disease. - Pertussis (whooping cough): reduces incidence and severity of pertussis infections. - Poliomyelitis: safeguards against poliovirus infection and paralytic disease. - Haemophilus influenzae type b: prevents invasive Hib disease such as meningitis and pneumonia.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: localized erythema or edema. - Fever: low‑grade temperature elevation within 24‑48 hours. - Irritability: increased fussiness in infants. - Loss of appetite: temporary reduction in feeding. - Headache: mild headache reported in some recipients.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: rare neurologic events following vaccination. - High fever (>40 °C): may be accompanied by febrile seizures. - Apnea: especially in premature infants. - Guillain‑Barré syndrome: extremely rare demyelinating neuropathy. - Severe local reaction: necrosis or abscess formation at injection site.

Infanrix IPV Hib should be administered according to national immunization schedules and under professional supervision. - Age: give only to infants and children as recommended by health authorities. - Allergy: avoid if the patient has a known hypersensitivity to any vaccine component. - Immunocompromised status: use with caution; immune response may be reduced. - Concurrent vaccines: follow recommended intervals when co‑administering other vaccines. - Pregnancy: safety not established; consult a healthcare provider before use. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Vaccines may interact with other biologics or immunomodulating agents. Major Interactions (Avoid): - Live viral vaccines: do not administer simultaneously with Infanrix IPV Hib. - Blood products containing immunoglobulins: may neutralize vaccine antigens. Moderate Interactions (Monitor Closely): - Antipyretics (e.g., acetaminophen): may mask post‑vaccination fever. - Corticosteroids: high‑dose therapy could diminish antibody response. - Immunosuppressive drugs: may require timing adjustments to achieve optimal immunity.